Optic pathway gliomas and brainstem gliomas are the predominant intracrania
l neoplasms associated with neurofibromatosis type 1 (NF1). Before the past
15 years, studies of optic pathway gliomas in NF1 were hampered by the ina
ccurate diagnosis of NF1, the unavailability of noninvasive neuroimaging te
chniques, and the frequent rendering of what would now be considered unnece
ssary, overly aggressive therapy. When studied systematically, these tumors
behave in a much more benign fashion than their counterparts in children w
ho do not have NF1. While they may cause symptoms in as many of 50% of case
s, progression to the point where specific intervention is deemed necessary
is unusual. Consequently, screening neuroimaging of asymptomatic patients
is unwarranted. Because optic pathway tumors universally arise in children
younger than 7 years of age, all such children should undergo yearly ophtha
lmologic evaluations and annual assessments of growth to monitor for signs
of precocious puberty. Am. J. Med. Genet. (Semin. Med. Genet.) 89:38-44, 19
99. (C) 1999 Wiley-Liss, Inc.